Alexion's Soliris Blood Drug Draws New Patent Cases
Just days after Alexion Pharmaceuticals Inc.'s blood antibody drug Soliris was approved by the United States Food and Drug Administration, two parties have filed a lawsuit claiming the drug infringes on...To view the full article, register now.
Already a subscriber? Click here to view full article